Ulrik Niels Lassen
Clinical Professor
- Published
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
Abdul Razak, A. R., Mau-Sørensen, M., Gabrail, N. Y., Gerecitano, J. F., Shields, A. F., Unger, T. J., Saint-Martin, J. R., Carlson, R., Landesman, Y., McCauley, D., Rashal, T., Lassen, Ulrik Niels, Kim, R., Stayner, L., Mirza, M. R., Kauffman, M., Shacham, S. & Mahipal, A., Dec 2016, In: Journal of Clinical Oncology. 34, 34, p. 4142-4150 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Application of cell-free DNA for genomic tumor profiling: a feasibility study
Ahlborn, L. B., Rohrberg, K. S., Gabrielaite, M., Tuxen, I. V., Yde, C. W., Spanggaard, I., Santoni Rugiu, Eric, Nielsen, Finn Cilius, Lassen, Ulrik Niels, Mau-Sorensen, M. & Østrup, O., Feb 2019, In: OncoTarget. 10, 14, p. 1388-1398Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Concordance of mutation detection in circulating tumor DNA in early clinical trials using different blood collection protocols
Ahlborn, L. B., Madsen, M., Jonson, L., Nielsen, Finn Cilius, Lassen, Ulrik Niels, Yde, C. W. & Mau-Sorensen, M., 2017, In: Clinical Laboratory. 63, 10, p. 1755-1759Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Ahlborn, L. B., Tuxen, I. V., Mouliere, F., Kinalis, S., Schmidt, A. Y., Rohrberg, K. S., Santoni Rugiu, Eric, Nielsen, Finn Cilius, Lassen, Ulrik Niels, Yde, C. W., Oestrup, O. & Mau-Sorensen, M., 2018, In: OncoTarget. 9, 66, p. 32570-32579Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2
Alanin, M. C., Klausen, C., Cayé-Thomasen, Per, Thomsen, C., Fugleholm, K., Poulsgaard, L., Lassen, Ulrik Niels, Mau-Sorensen, M. & Hofland, K. F., Dec 2015, In: European Archives of Oto-Rhino-Laryngology. 272, 12, p. 3627-3633 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2: a retrospective case series
Alanin, M. C., Klausen, C., Cayé-Thomasen, Per, Thomsen, C., Fugleholm, Kåre, Poulsgaard, L., Lassen, Ulrik Niels, Mau-Sørensen, M. & Hofland, K. F., 2016, In: International Journal of Neuroscience. 126, 11, p. 1002-6 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A prospective PET study of patients with glioblastoma multiforme
Andersen, P. B., Blinkenberg, M., Lassen, Ulrik Niels, Kosteljanetz, M., Wagner, A., Poulsen, H. S., Sørensen, Per Soelberg & Paulson, Olaf B., Jun 2006, In: Acta Neurologica Scandinavica. 113, 6, p. 412-8 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome
Araujo B de Lima, V., Borch, A., Hansen, M., Draghi, A., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, Apr 2020, In: Cytotherapy. 22, 4, p. 204-213 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
Araujo B. de Lima, V., Hansen, M., Spanggaard, I., Rohrberg, K., Reker Hadrup, S., Lassen, Ulrik Niels & Svane, Inge Marie, 25 Mar 2021, In: Frontiers in Oncology. 11, 11 p., 558248.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein
Bang-Christensen, S. R., Pedersen, R. S., Pereira, M. A., Clausen, T. M., Løppke, C., Sand, N. T., Ahrens, T. D., Jørgensen, A. M., Lim, Y. C., Goksøyr, L., Choudhary, S., Gustavsson, T., Dagil, R., Daugaard, M., Sander, A. F., Torp, M. H., Søgaard, M., Theander, T. G., Østrup, O., Lassen, U. & 3 others, , 2019, In: Cells. 8, 9, 21 p., 998.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
New pathogenic germline variants identified in mesothelioma
Belcaid, L., Bertelsen, B., Wadt, Karin Anna Wallentin, Tuxen, I., Spanggaard, I., Højgaard, M., Sørensen, Jens Benn, Ravn, J., Lassen, Ulrik Niels, Nielsen, Finn Cilius, Rohrberg, K. & Westmose Yde, C., 2023, In: Lung Cancer. 179, 8 p., 107172.Research output: Contribution to journal › Review › Research › peer-review
- Published
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Bertelsen, B., Tuxen, I. V., Yde, C. W., Gabrielaite, M., Torp, M. H., Kinalis, S., Oestrup, O., Rohrberg, K., Spangaard, I., Santoni Rugiu, Eric, Wadt, Karin Anna Wallentin, Mau-Sorensen, M., Lassen, Ulrik Niels & Nielsen, Finn Cilius, 2019, In: npj Genomic Medicine. 4, 1, 11 p., 13.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Putting data to work for precision medicine
Bjerrum, A. & Lassen, Ulrik Niels, 2023, In: Cell Reports Medicine. 4, 7, 3 p., 101090.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours
Bono, P., Massard, C., Peltola, K. J., Azaro, A., Italiano, A., Kristeleit, R. S., Curigliano, G., Lassen, Ulrik Niels, Arkenau, H. T., Hakulinen, P., Garratt, C., Ikonen, T., Mustonen, M. V. J. & Rodon, J. A., 2020, In: ESMO Open. 5, 6, 11 p., e001081.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
Borch, A., Bjerregaard, A. M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, Inge Marie, Nielsen, Finn Cilius, Funt, S. A., Lassen, Ulrik Niels & Hadrup, S. R., 2023, In: Frontiers in Genetics. 14, 13 p., 1058605.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer
Borghaei, H., Alpaugh, K., Hedlund, G., Forsberg, G., Langer, C., Rogatko, A., Hawkins, R., Dueland, S., Lassen, Ulrik Niels & Cohen, R. B., 2009, In: Journal of Clinical Oncology. 27, 25, p. 4116-23 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study
Briggs, A., Paracha, N., Rosettie, K., Upton, A., Bokemeyer, C., Lassen, Ulrik Niels & Sullivan, S. D., Jan 2022, In: Oncology. 100, 2, p. 124–129 6 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Changes in key recruitment performance metrics from 2008-2019 in industrysponsored phase III clinical trials registered at ClinicalTrials.gov
Brøgger-Mikkelsen, Mette, Zibert, J. R., Andersen, A. D., Lassen, Ulrik Niels, Hædersdal, Merete, Ali, Z. & Thomsen, Simon Francis, 2022, In: PLoS ONE. 17, 7 July, p. 1-15 e0271819.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
Carlson, J. J., Italiano, A., Brose, M. S., Federman, N., Lassen, Ulrik Niels, Kummar, S. & Sullivan, S. D., 2022, In: American Journal of Managed Care. 28, p. S26-S32Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Cejalvo, J. M., Jacob, W., Fleitas Kanonnikoff, T., Felip, E., Navarro Mendivil, A., Martinez Garcia, M., Taus Garcia, A., Leighl, N., Lassen, Ulrik Niels, Mau-Soerensen, M., Adessi, C., Michielin, F., James, I., Ceppi, M., Hasmann, M., Weisser, M. & Cervantes, A., 2019, In: ESMO Open. 4, 4, 7 p., e000532.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The role of nuclear medicine in the diagnosis of cancer of unknown origin
Demir, H., Berk, F., Raderer, M., Plowman, P. N., Lassen, Ulrik Niels, Daugaard, G., Clausen, M., Bohuslavizki, K. H., Peters, M., Harmer, C., Malamitsi, J. & Aktolun, C., Jun 2004, In: American Journal of Nuclear Medicine and Molecular Imaging. 48, 2, p. 164-73 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors
Dienstmann, R., Lassen, Ulrik Niels, Cebon, J., Desai, J., Brown, M. P., Evers, S., Su, F., Zhang, W., Boisserie, F., Lestini, B., Schostack, K., Meresse, V. & Tabernero, J., Apr 2016, In: Targeted Oncology. 11, 2, p. 149-56 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase II activity of belinostat (PXD-101), carboplatin, and paclitaxel in women with previously treated ovarian cancer
Dizon, D. S., Damstrup, L., Finkler, N. J., Lassen, Ulrik Niels, Celano, P., Glasspool, R., Crowley, E., Lichenstein, H. S., Knoblach, P. & Penson, R. T., Jul 2012, In: International Journal of Gynecological Cancer. 22, 6, p. 979-86 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations
Dombernowsky, T., Hædersdal, Merete, Lassen, Ulrik Niels & Thomsen, Simon Francis, 2019, In: Trials. 20, 12 p., 708.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical trial allocation in multinational pharmaceutical companies: a qualitative study on influential factors
Dombernowsky, T., Hædersdal, Merete, Lassen, Ulrik Niels & Thomsen, Simon Francis, Jun 2017, In: Pharmacology Research & Perspectives. 5, 3, 9 p., e00317.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities
Dombernowsky, T., Hædersdal, Merete, Lassen, Ulrik Niels & Thomsen, Simon Francis, Jul 2017, In: B M J Open. 7, 7, 10 p., e015579.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase Fusion–Positive Lung Cancers
Drilon, A., Tan, D. S. W., Lassen, Ulrik Niels, Leyvraz, S., Liu, Y., Patel, J. D., Rosen, L., Solomon, B., Norenberg, R., Dima, L., Brega, N., Shen, L., Moreno, V., Kummar, S. & Lin, J. J., 2022, In: JCO Precision Oncology. 6, 10 p., e2100418.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
Drilon, A., Laetsch, T. W., Kummar, S., DuBois, S. G., Lassen, U. N., Demetri, G. D., Nathenson, M., Doebele, R. C., Farago, A. F., Pappo, A. S., Turpin, B., Dowlati, A., Brose, M. S., Mascarenhas, L., Federman, N., Berlin, J., El-Deiry, W. S., Baik, C., Deeken, J., Boni, V. & 18 others, , 2018, In: The New England Journal of Medicine. 378, 8, p. 731-739Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Precision cancer medicine: Concepts, current practice, and future developments
Edsjö, A., Holmquist, L., Geoerger, B., Nowak, F., Gomon, G., Alix-Panabières, C., Ploeger, C., Lassen, Ulrik Niels, Le Tourneau, C., Lehtiö, J., Ott, P. A., von Deimling, A., Fröhling, S., Voest, E., Klauschen, F., Dienstmann, R., Alshibany, A., Siu, L. L. & Stenzinger, A., 2023, In: Journal of Internal Medicine. 294, 4, p. 455-481 27 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy
Eriksen, M., Yde, C. W., Ahlborn, L. B., Qvortrup, Camilla, Lassen, Ulrik Niels, Højgaard, M., Spanggaard, I. & Rohrberg, K. S., 2022, In: European Journal of Cancer. 174, S1, p. S118Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
Even, C., Lassen, Ulrik Niels, Merchan, J., Le Tourneau, C., Soria, J. C., Ferte, C., Ricci, F., Diener, J. T., Yuen, E., Smith, C., Oakley, G. J., Benhadji, K. A. & Massard, C., Apr 2020, In: Investigational New Drugs. 38, 2, p. 402-409Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
Fischer, Barbara Malene Bjerregaard, Mortensen, J., Langer, Seppo W., Loft, A., Berthelsen, A. K., Petersen, B. I., Daugaard, G., Lassen, Ulrik Niels & Hansen, H. H., Feb 2007, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 18, 2, p. 338-45 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PET in staging of patients with small cell lung cancer - preliminary results
Fischer, Barbara Malene Bjerregaard, Mortensen, Jann, Langer, Seppo W., Eigtved, A., Berthelsen, A., Lassen, Ulrik Niels, Daugaard, G. & Hansen, H., Aug 2004, In: European Journal of Nuclear Medicine and Molecular Imaging. 31, p. S352-S352 1 p.Research output: Contribution to journal › Conference article › Research › peer-review
- Published
Preoperative staging of lung cancer with combined PET-CT
Fischer, B., Lassen, U., Mortensen, J., Larsen, S., Loft, A., Bertelsen, A., Ravn, J., Clementsen, P., Høgholm, A., Larsen, K., Rasmussen, T., Keiding, S., Dirksen, A., Gerke, O., Skov, B., Steffensen, I., Hansen, H., Vilmann, P., Jacobsen, G., Backer, V. & 5 others, , 2009, In: New England Journal of Medicine. 361, 1, p. 32-9 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
Fischer, B. M., Mortensen, Jann, Hansen, H., Vilmann, Peter, Larsen, S., Loft, A., Bertelsen, A., Ravn, J., Clementsen, P., Høegholm, A., Larsen, K. R., Dirksen, A., Skov, B. G., Krasnik, M., Højgaard, Liselotte, Lassen, Ulrik Niels, Larsen, S. S., Jakobsen, A. L. & Berthelsen, A. K., 1 Apr 2011, In: Thorax. 66, 4, p. 294-300 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PET/CT imaging in response evaluation of patients with small cell lung cancer
Fischer, Barbara Malene Bjerregaard, Mortensen, Jann, Langer, Seppo W., Loft, A., Berthelsen, A. K., Daugaard, G., Lassen, Ulrik Niels & Hansen, H. H., Oct 2006, In: Lung Cancer. 54, 1, p. 41-9 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
PET-CT in preoperative staging of lung cancer
Fischer, Barbara Malene Bjerregaard, Lassen, Ulrik Niels & Højgaard, Liselotte, 10 Mar 2011, In: New England Journal of Medicine. 364, 10, p. 980-1 2 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation
Fougner, V., Hasselbalch, B., Lassen, Ulrik Niels, Weischenfeldt, Joachim Lütken, Poulsen, H. S. & Urup, T., 2022, In: Neuro-Oncology Advances. 4, 1, vdac157.Research output: Contribution to journal › Review › Research › peer-review
- Published
Distress and perceived information among patients in phase I trials and their relatives: A prospective study
Gad, K. T., Dalton, Susanne Oksbjerg, Envold, P. B., Duun-henriksen, A. K., Lassen, Ulrik Niels, Mau-sørensen, M., Rohrberg, K. S., Spanggaard, I., Von Heymann, A., Høeg, B. L. & Johansen, Christoffer, 1 Sep 2020, In: Annals of Oncology. 31, p. S497 1 p., 591P .Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Patients in phase 1 cancer trials: psychological distress and understanding of trial information
Gad, K. T., Lassen, Ulrik Niels, Duun-Henriksen, A. K., Dalton, Susanne Oksbjerg, Mau-Sørensen, M., Bidstrup, P. E., Høeg, B. L., Rohrberg, K. S., Spanggard, I., von Heymann, A. & Johansen, Christoffer, 2022, In: Acta Oncologica. 61, 3, p. 341-348 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Patient information in phase 1 trials: A systematic review
Gad, K. T., Lassen, Ulrik Niels, Mau-Søerensen, M., Høybye, M. T. & Johansen, Christoffer, Mar 2018, In: Psycho-Oncology. 27, 3, p. 768-780Research output: Contribution to journal › Review › Research › peer-review
- Published
Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study
Gad, K. T., Johansen, Christoffer, Duun-Henriksen, A. K., Krøyer, A., Olsen, M. H., Lassen, Ulrik Niels, Mau-Sørensen, M. & Dalton, Susanne Oksbjerg, 1 May 2019, In: Journal of Clinical Oncology. 37, 13, p. 1111-1119Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers
Garcia‐foncillas, J., Bokemeyer, C., Italiano, A., Keating, K., Paracha, N., Fellous, M., Marian, M., Fillbrunn, M., Gao, W., Ayyagari, R. & Lassen, Ulrik Niels, 2022, In: Cancers. 14, 7, 15 p., 1793.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer
Grunnet, M., Christensen, I. J., Lassen, Ulrik Niels, Jensen, L. H., Lydolph, M., Knox, J. J., McNamara, M. G., Jitlal, M., Wasan, H., Bridgewater, J., Valle, J. W. & Mau-Sørensen, M., Jul 2015, In: European journal of cancer (Oxford, England : 1990). 51, 11, p. 1381-8 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin
Hassan, R., Alewine, C., Mian, I., Spreafico, A., Siu, L. L., Gomez-Roca, C., Delord, J. P., Italiano, A., Lassen, Ulrik Niels, Soria, J. C., Bahleda, R., Thomas, A., Steinberg, S. M., Peer, C. J., Figg, W. D., Niederfellner, G., Méresse Naegelen, V. & Pastan, I., 2020, In: Cancer. 126, 22, p. 4936-4947 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Hasselbalch, B., Lassen, Ulrik Niels, Hansen, S., Holmberg, M., Sørensen, M., Kosteljanetz, M., Broholm, H., Stockhausen, M. & Poulsen, H. S., May 2010, In: Neuro-Oncology. 12, 5, p. 508-16 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan
Hasselbalch, B., Eriksen, J. G., Broholm, H., Christensen, I. J., Grunnet, K., Horsman, M. R., Poulsen, H. S., Stockhausen, M. & Lassen, Ulrik Niels, Aug 2010, In: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 118, 8, p. 585-94 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial
Hasselbalch, B., Lassen, Ulrik Niels, Hansen, S., Holmberg, M., Sørensen, M., Kosteljanetz, M., Broholm, H., Stockhausen, M. & Poulsen, H. S., 1 May 2010, In: Neuro-Oncology. 12, 5, p. 508-16 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signaling
Hasselbalch, B., Lassen, Ulrik Niels, Poulsen, H. S. & Stockhausen, M., 1 Oct 2010, In: Cancer Investigation. 28, 8, p. 775-87 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan
Hasselbalch, B., Eriksen, J. G., Broholm, H., Christensen, I. J., Grunnet, K., Horsman, M. R., Poulsen, H. S., Stockhausen, M. & Lassen, Ulrik Niels, 1 Aug 2010, In: Acta Pathologica Microbiologica et Immunologica Scandinavica. 118, 8, p. 585-94 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Actively personalized vaccination trial for newly diagnosed glioblastoma
Hilf, N., Kuttruff-Coqui, S., Frenzel, K., Bukur, V., Stevanović, S., Gouttefangeas, C., Platten, M., Tabatabai, G., Dutoit, V., van der Burg, S. H., thor Straten, P., Martínez-Ricarte, F., Ponsati, B., Okada, H., Lassen, U., Admon, A., Ottensmeier, C. H., Ulges, A., Kreiter, S., von Deimling, A. & 44 others, , 2019, In: Nature. 565, 7738, p. 240-245 6 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study
Hofland, K. F., Hansen, S., Sorensen, M., Engelholm, S., Schultz, H. P., Muhic, A., Grunnet, K., Ask, A., Costa, J. C., Kristiansen, C., Thomsen, C., Poulsen, H. S. & Lassen, Ulrik Niels, Jul 2014, In: Acta Oncologica. 53, 7, p. 939-944 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A phase I study of concurrent chemoradiotherapy and cetuximab for locally advanced esophageal cancer
Holländer, C., Baeksgaard, L., Sorensen, M., Albertsson, P., Damstrup, L. & Lassen, Ulrik Niels, Sep 2012, In: Anticancer Research. 32, 9, p. 4019-23 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer
Hong, D. S., Concin, N., Vergote, I., de Bono, J. S., Slomovitz, B. M., Drew, Y., Arkenau, H-T., Machiels, J-P., Spicer, J. F., Jones, R., Forster, M. D., Cornez, N., Gennigens, C., Johnson, M. L., Thistlethwaite, F. C., Rangwala, R. A., Ghatta, S., Windfeld, K., Harris, J. R., Lassen, U. N. & 1 others, , 15 Mar 2020, In: Clinical Cancer Research. 26, 6, p. 1220-1228 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Larotrectinib versus prior therapies in tropomyosin receptor kinase fusion cancer: An intra-patient comparative analysis
Italiano, A., Nanda, S., Briggs, A., Garcia-Foncillas, J., Lassen, Ulrik Niels, Vassal, G., Kummar, S., van Tilburg, C. M., Hong, D. S., Laetsch, T. W., Keating, K., Reeves, J. A., Fellous, M., Childs, B. H., Drilon, A. & Hyman, D. M., 2020, In: Cancers. 12, 11, p. 1-10 10 p., 3246.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact
Jacobsen, I. C., Spanggaard, I., Højgaard, M., Belcaid, L., Qvortrup, Camilla, Yde, C. W., Schmidt, A. Y., Nielsen, Finn Cilius, Willemoe, G. L., Dam, M. S., Lassen, Ulrik Niels & Staal Rohrberg, K., 2022, In: Acta Oncologica. 61, 12, p. 1499-1506 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
Jacobsen, K., Bertran-Alamillo, J., Molina, M. A., Teixidó, C., Karachaliou, N., Pedersen, M. H., Castellví, J., Garzón, M., Codony-Servat, C., Codony-Servat, J., Giménez-Capitán, A., Drozdowskyj, A., Viteri, S., Larsen, M. R., Lassen, Ulrik Niels, Felip, E., Bivona, T. G., Ditzel, H. J. & Rosell, R., 2017, In: Nature Communications. 8, 14 p., 410.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Irinotecan and bevacizumab in recurrent glioblastoma multiforme
Jakobsen, J. N., Hasselbalch, B., Stockhausen, M., Lassen, Ulrik Niels & Poulsen, H. S., 1 Apr 2011, In: Expert Opinion on Pharmacotherapy. 12, 5, p. 825-33 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Late effects–the new focus of follow-up
Johansen, Christoffer, von Heymann, A., Rafn, B. S., Borgquist, S., Christiansen, P., Christensen, P., Zachariae, R., Pappot, Helle & Lassen, Ulrik Niels, 2022, In: Acta Oncologica. 61, 10, p. 1163-1164Research output: Contribution to journal › Editorial › Research
- Published
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
Johansen, M. D., Urup, T., Holst, C. B., Christensen, I. J., Grunnet, K., Lassen, Ulrik Niels, Friis, S. & Poulsen, H. S., 2018, In: Cancer Investigation. 36, 9-10, p. 512-519 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial
Kringelbach, T., Højgaard, M., Rohrberg, K., Spanggaard, I., Laursen, Britt Elmedal, Ladekarl, M., Haslund, C. A., Harsløf, L., Belcaid, L., Gehl, Julie, Søndergaard, L., Eefsen, R. L., Hansen, K. H., Kodahl, A. R., Jensen, L. H., Holt, M. I., Oellegaard, T. H., Yde, C. W., Ahlborn, L. B. & Lassen, Ulrik Niels, 2023, In: BMC Cancer. 23, 1, 12 p., 182.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
TRK Inhibition: A New Tumor-Agnostic Treatment Strategy
Kummar, S. & Lassen, Ulrik Niels, 2018, In: Targeted Oncology. 13, 5, p. 545-556Research output: Contribution to journal › Review › Research › peer-review
- Published
Endoscopic ultrasound guided biopsy performed routinely in lung cancer staging spares futile thoracotomies: preliminary results from a randomised clinical trial
Larsen, S. S., Vilmann, Peter, Krasnik, M., Dirksen, A., Clementsen, P., Maltbaek, N., Lassen, Ulrik Niels, Skov, B. G. & Jacobsen, G. K., Sep 2005, In: Lung Cancer. 49, 3, p. 377-85 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A Comparison of Endoscopic Ultrasound Guided Biopsy and Positron Emission Tomography with Integrated Computed Tomography in Lung Cancer Staging
Larsen, S. S., Vilmann, Peter, Krasnik, K., Dirksen, A., Clementsen, P., Skov, B. G., Jacobsen, G. K., Lassen, Ulrik Niels, Eigtved, A., Berthelsen, A. K., Mortensen, J. & Højgaard, Liselotte, Jan 2009, In: Current Health Sciences Journal. 35, 1, p. 5-12 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours
Lassen, Ulrik Niels, Nielsen, Dorte Lisbet, Sørensen, M., Winstedt, L., Niskanen, T., Stenberg, Y., Pakola, S., Stassen, J. & Glazer, S., 14 Feb 2012, In: B J C. 106, 4, p. 678-84 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Whole-body FDG-PET in patients with stage I non-seminomatous germ cell tumours
Lassen, Ulrik Niels, Daugaard, G., Eigtved, A., Højgaard, L., Nielsen, K. D. & Rørth, M., 2003, In: European Journal of Nuclear Medicine and Molecular Imaging. 30, 3, p. 396-402 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients
Lassen, Ulrik Niels, Osterlind, K., Hansen, M., Dombernowsky, P., Bergman, B. & Hansen, H. H., May 1995, In: Journal of Clinical Oncology. 13, 5, p. 1215-20 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
18F-FDG whole body positron emission tomography (PET) in patients with unknown primary tumours (UPT)
Lassen, Ulrik Niels, Daugaard, G., Eigtved, A., Damgaard, K. & Friberg, L., Jul 1999, In: European journal of cancer (Oxford, England : 1990). 35, 7, p. 1076-82 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up
Lassen, Ulrik Niels, Kristjansen, P. E., Osterlind, K., Bergman, B., Sigsgaard, T. C., Hirsch, F. R., Hansen, M., Dombernowsky, P. & Hansen, H. H., Apr 1996, In: Annals of Oncology. 7, 4, p. 365-71 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously in treated small cell lung cancer and extensive disease: Final results.
Lassen, Ulrik Niels, Sorensen, M., Jensen, P., Langer, Seppo W., Jensen, B., Jeppesen, N., Rytter, C., Mellemgaard, A., Hansen, Oddur & Osterlind, K., 15 Jul 2004, In: Journal of Clinical Oncology. 22, 14, p. 667S-667S 1 p.Research output: Contribution to journal › Conference article › Research › peer-review
- Published
A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours
Lassen, Ulrik Niels, Molife, L. R., Sorensen, J. M., Engelholm, S., Vidal, L., Sinha, R., Penson, R. T., Buhl-Jensen, P., Crowley, E., Tjornelund, J., Knoblauch, P., de Bono, J. S. & Buhl-Jensen, P., 29 Jun 2010, In: B J C. 103, 1, p. 12-7 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Surgery in limited stage small cell lung cancer
Lassen, Ulrik Niels & Hansen, H. H., Apr 1999, In: Cancer Treatment Reviews. 25, 2, p. 67-72 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study
Lassen, Ulrik Niels, Kristjansen, P. E., Wagner, A., Kosteljanetz, M. & Poulsen, H. S., Jun 1999, In: Journal of Neuro-Oncology. 43, 2, p. 161-6 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumours
Lassen, Ulrik Niels, Miller, W. H., Hotte, S., Evans, T. R. J., Kollmansberger, C., Adamson, D., Nielsen, Dorte Lisbet, Spicer, J., Chen, E., Meyer, T., Brown, K., Rafi, R. & Sawyer, M. B., 2013, In: Cancer Chemotherapy and Pharmacology. 71, 2, p. 543-549 7 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Amantadin til influenza
Lassen, Ulrik Niels & Hornsleth, A., 20 Jul 1992, In: Ugeskrift for Laeger. 154, 30, p. 2099-103 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography
Lassen, Ulrik Niels, Andersen, P., Daugaard, G., Holm, S., Jensen, M., Svarer, C., Poulsen, H. S. & Paulson, Olaf B., Nov 1998, In: Clinical Cancer Research. 4, 11, p. 2591-7 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Brain metastases in small-cell lung cancer
Lassen, Ulrik Niels, Kristjansen, P. E. & Hansen, H. H., Nov 1995, In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 6, 9, p. 941-4 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
Lassen, Ulrik Niels, Osterlind, K., Hirsch, F. R., Bergman, B., Dombernowsky, P. & Hansen, H. H., Feb 1999, In: B J C. 79, 3-4, p. 515-9 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Outcome of combination chemotherapy in extensive stage small-cell lung cancer: any treatment related progress?
Lassen, Ulrik Niels, Hirsch, F. R., Osterlind, K., Bergman, B. & Dombernowsky, P., Jun 1998, In: Lung Cancer. 20, 3, p. 151-60 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Småcellet lungecancer
Lassen, Ulrik Niels & Hansen, H. H., 5 Aug 1996, In: Ugeskrift for Laeger. 158, 32, p. 4517-9 3 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Lassen, Ulrik Niels, Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., 2013, In: Anticancer Research. 33, 4, p. 1657-1660 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Combining PARP inhibition with PD-1 inhibitors
Lassen, Ulrik Niels, 2019, In: The Lancet Oncology. 20, 9, p. 1196-1198 3 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma
Lassen, Ulrik Niels, Chinot, O. L., McBain, C., Mau-Sørensen, M., Larsen, V. A., Barrie, M., Roth, P., Krieter, O., Wang, K., Habben, K., Tessier, J., Lahr, A. & Weller, M., Jul 2015, In: Neuro-Oncology. 17, 7, p. 1007-15 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
A Phase I-II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas
Lassen, Ulrik Niels, Jensen, L. H., Sorensen, M., Rohrberg, K. S., Ujmajuridze, Z. & Jakobsen, A., 1 Apr 2011, In: Acta Oncologica. 50, 3, p. 448-54 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
FDG-PET imaging in small cell lung cancer: any value?
Lassen, Ulrik Niels, Jul 2002, In: Lung Cancer. 37, 1, p. 7Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase II study of bevacizumab and temsirolimus combination therapy for recurrent glioblastoma multiforme
Lassen, Ulrik Niels, Sorensen, M., Gaziel, T. B., Hasselbalch, B. & Poulsen, H. S., Apr 2013, In: Anticancer Research. 33, 4, p. 1657-60 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Entrectinib for ROS1 fusion-positive NSCLC and NTRK fusion-positive solid tumours
Lassen, Ulrik Niels, 2020, In: Lancet Oncology. 21, 2, p. 193-194Research output: Contribution to journal › Comment/debate › Research
- Published
How I treat NTRK gene fusion-positive cancers
Lassen, Ulrik Niels, 2019, In: ESMO Open. 4, Suppl. 2, 3 p., e000612.Research output: Contribution to journal › Review › Research › peer-review
- Published
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers
Lassen, Ulrik Niels, Meulendijks, D., Siu, L. L., Karanikas, V., Mau-Sorensen, M., Schellens, J. H. M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., Vega-Harring, S. M., Jarutat, T., Geho, D., Wang, K., DeMario, M. & Goss, G. D., 15 Jan 2015, In: Clinical Cancer Research. 21, 2, p. 258-66 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non–Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies
Lazar, V., Girard, N., Raymond, E., Martini, J., Galbraith, S., Raynaud, J., Bresson, C., Solomon, B., Magidi, S., Nechushtan, H., Onn, A., Berger, R., Chen, H., Al-omari, A., Ikeda, S., Lassen, U., Sekacheva, M., Felip, E., Tabernero, J., Batist, G. & 10 others, , 2022, In: JCO Precision Oncology. 6, 12 p., e2200072.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung
Lazar, V., Raynaud, J., Magidi, S., Bresson, C., Martini, J. F., Galbraith, S., Wunder, F., Onn, A., Batist, G., Girard, N., Lassen, U., Pramesh, C. S., Al-Omari, A., Ikeda, S., Berchem, G., Blay, J. Y., Solomon, B., Felip, E., Tabernero, J., Rubin, E. & 5 others, , 2022, In: Therapeutic Advances in Medical Oncology. 14, p. 1-15 15 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Total burden of disease in cancer patients at diagnosis—a Danish nationwide study of multimorbidity and redeemed medication
Loeppenthin, K., Dalton, Susanne Oksbjerg, Johansen, Christoffer, Andersen, E., Christensen, Mikkel Bring, Pappot, Helle, Petersen, L. N., Thisted, L. B., Frølich, A., Mortensen, C. E., Lassen, Ulrik Niels, Ørsted, J. & Bidstrup, P. E., 15 Sep 2020, In: British Journal of Cancer. 123, 6, p. 1033-1040 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
Lokhorst, H. M., Plesner, T., Laubach, J. P., Nahi, H., Gimsing, P., Hansson, M., Minnema, M. C., Lassen, U., Krejcik, J., Palumbo, A., van de Donk, N. W. C. J., Ahmadi, T., Khan, I., Uhlar, C. M., Wang, J., Sasser, A. K., Losic, N., Lisby, S., Basse, L., Brun, N. & 1 others, , 24 Sep 2015, In: New England Journal of Medicine. 373, 13, p. 1207-19 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
Massard, C., Azaro, A., Soria, J., Lassen, Ulrik Niels, Le Tourneau, C., Sarker, D., Smith, C., Ohnmacht, U., Oakley, G., Patel, B. K. R., Yuen, E. S. M., Benhadji, K. A. & Rodon, J., 2018, In: Annals of oncology : official journal of the European Society for Medical Oncology. 29, 9, p. 1911-1917 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3
Mau-Sørensen, M., Dittrich, C., Dienstmann, R., Lassen, Ulrik Niels, Büchler, W., Martinius, H. & Tabernero, J., May 2015, In: Cancer Chemotherapy and Pharmacology. 75, 5, p. 1065-73 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Dynamics of mutant BRAF V600E in free circulating DNA (fcDNA) of non-melanoma cancer patients (pts) in response to treatment with BRAF and MEK/EGFR inhibitors
Mau-Sørensen, M., Ahlborn, L. B., Jønson, L., Oestrup, O., Hasselby, Jane Preuss, Santoni Rugiu, Eric, Nielsen, Finn Cilius, Lassen, Ulrik Niels & Yde, C. W., 2016, In: Journal of Clinical Oncology. 34, 15 (Suppl. S), 11531.Research output: Contribution to journal › Conference abstract in journal › Research
- Published
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Meulendijks, D., Jacob, W., Voest, E. E., Mau-Sorensen, M., Martinez-Garcia, M., Taus, A., Fleitas, T., Cervantes, A., Lolkema, M. P., Langenberg, M. H. G., De Jonge, M. J., Sleijfer, S., Han, J-Y., Calles, A., Felip, E., Kim, S-W., Schellens, J. H. M., Wilson, S., Thomas, M., Ceppi, M. & 11 others, , 2017, In: Clinical Cancer Research. 23, 18, p. 5406-5415Research output: Contribution to journal › Journal article › Research › peer-review
- Published
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors
Meulendijks, D., Jacob, W., Martinez-Garcia, M., Taus, A., Lolkema, M. P., Voest, E. E., Langenberg, M. H. G., Fleitas Kanonnikoff, T., Cervantes, A., De Jonge, M. J., Sleijfer, S., Mau-Sørensen, M., Thomas, M., Ceppi, M., Meneses-Lorente, G., James, I., Adessi, C., Michielin, F., Abiraj, K., Bossenmaier, B. & 3 others, , 15 Feb 2016, In: Clinical Cancer Research. 22, 4, p. 877-85 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors
Meulendijks, D., Lassen, Ulrik Niels, Siu, L. L., Huitema, A. D. R., Karanikas, V., Mau-Sørensen, M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., Vega-Harring, S. M., Jarutat, T., Geho, D., Wang, K., DeMario, M., Goss, G. D. & Schellens, J. H. M., 15 Feb 2016, In: Clinical Cancer Research. 22, 4, p. 858-67 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
Michaelsen, Signe Regner, Staberg, M., Pedersen, H., Jensen, K. E., Majewski, W., Broholm, H., Nedergaard, M. K., Meulengracht, C., Urup, T., Villingshøj, M., Lukacova, S., Skjøth-Rasmussen, J., Brennum, J., Kjær, Andreas, Lassen, Ulrik Niels, Stockhausen, M., Poulsen, H. S. & Hamerlik, P., 2018, In: Neuro-Oncology. 20, 11, p. 1462-1474Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4952653
Most downloads
-
481
downloads
Clinical trial allocation in multinational pharmaceutical companies: a qualitative study on influential factors
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
224
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
175
downloads
Hallmarks of glioblastoma: a systematic review
Research output: Contribution to journal › Review › Research › peer-review
Published